VATY POITEVIEN: Open Payments
NPI 1982814034 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$150 in 5 payments from 4 companies in 2025. Trend: 2023 $78 · 2024 $59 · 2025 $150
Food & beverage: $150
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $63 |
| Alkermes, Inc. | 1 | $34 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| ViiV Healthcare Company | 1 | $23 |
Products named: ARISTADA, PIFELTRO, Descovy, APRETUDE.
Industry payments across NY — which companies pay providers there.
